Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 72

1.

Impact of initial treatment outcome on long-term costs of depression: a 3-year nationwide follow-up study in Taiwan.

Pan YJ, Knapp M, McCrone P.

Psychol Med. 2014 Apr;44(6):1147-58. doi: 10.1017/S0033291713001700. Epub 2013 Jul 18.

PMID:
23866061
2.

Depression, health-related quality of life, and medical cost outcomes of receiving recommended levels of antidepressant treatment.

Revicki DA, Simon GE, Chan K, Katon W, Heiligenstein J.

J Fam Pract. 1998 Dec;47(6):446-52.

PMID:
9866670
3.
4.

Course and cost of treatment for depression with fluoxetine, paroxetine, and sertraline.

Russell JM, Berndt ER, Miceli R, Colucci S, Grudzinski AN.

Am J Manag Care. 1999 May;5(5):597-606.

5.

Long-term outcomes of initial antidepressant drug choice in a "real world" randomized trial.

Simon GE, Heiligenstein J, Revicki D, VonKorff M, Katon WJ, Ludman E, Grothaus L, Wagner E.

Arch Fam Med. 1999 Jul-Aug;8(4):319-25.

PMID:
10418538
6.

Initial treatment choice in depression: impact on medical expenditures.

Edgell ET, Hylan TR, Draugalis JR, Coons SJ.

Pharmacoeconomics. 2000 Apr;17(4):371-82.

PMID:
10947492
7.

Utilization of traditional Chinese medicine in patients treated for depression: a population-based study in Taiwan.

Pan YJ, Cheng IC, Yeh LL, Cho YM, Feng J.

Complement Ther Med. 2013 Jun;21(3):215-23. doi: 10.1016/j.ctim.2013.03.003. Epub 2013 Mar 31.

PMID:
23642954
8.

Treatment costs for depression with pain and cardiovascular comorbidities.

Pan YJ, Knapp M, Yeh LL, Chen YP, McCrone P.

J Psychiatr Res. 2013 Mar;47(3):329-36. doi: 10.1016/j.jpsychires.2012.11.005. Epub 2012 Dec 7.

PMID:
23228277
9.

Factors affecting early attrition and later treatment course of antidepressant treatment of depression in naturalistic settings: an 18-month nationwide population-based study.

Pan YJ, Liu SK, Yeh LL.

J Psychiatr Res. 2013 Jul;47(7):916-25. doi: 10.1016/j.jpsychires.2013.03.005. Epub 2013 Apr 5.

PMID:
23566422
10.

Economic impact of antidepressant treatment duration in naturalistic conditions.

Tournier M, Crott R, Gaudron Y, Verdoux H.

Acta Psychiatr Scand. 2013 May;127(5):365-72. doi: 10.1111/acps.12035. Epub 2012 Nov 26.

PMID:
23176590
11.

Differences in total medical costs across the SSRIs for the treatment of depression and anxiety.

Sheehan DV, Eaddy MT, Shah MB, Mauch RP.

Am J Manag Care. 2005 Oct;11(12 Suppl):S354-61.

12.

One-year costs of second-line therapies for depression.

Sullivan EM, Griffiths RI, Frank RG, Strauss MJ, Herbert RJ, Clouse J, Goldman HH.

J Clin Psychiatry. 2000 Apr;61(4):290-8.

PMID:
10830151
13.

Current issues in the economics of depression management.

Thompson D, Richardson E.

Curr Psychiatry Rep. 1999 Dec;1(2):125-34.

PMID:
11122914
14.

Impact of initiation timing of SSRI or SNRI on depressed adolescent healthcare utilization and costs.

Yu AP, Ben-Hamadi R, Wu EQ, Kaltenboeck A, Bergman R, Xie J, Blum S, Erder MH.

J Med Econ. 2011;14(4):508-15. doi: 10.3111/13696998.2011.593602. Epub 2011 Jun 21.

PMID:
21692605
15.

Economic impact of non-persistence to antidepressant therapy in the Quebec community-dwelling elderly population.

Tournier M, Moride Y, Crott R, du Fort GG, Ducruet T.

J Affect Disord. 2009 May;115(1-2):160-6. doi: 10.1016/j.jad.2008.07.004. Epub 2008 Aug 9.

PMID:
18694602
16.

Long-term outcome of cognitive behaviour therapy clinical trials in central Scotland.

Durham RC, Chambers JA, Power KG, Sharp DM, Macdonald RR, Major KA, Dow MG, Gumley AI.

Health Technol Assess. 2005 Nov;9(42):1-174. Review.

17.
18.

Cost-effectiveness of systematic depression treatment for high utilizers of general medical care.

Simon GE, Manning WG, Katzelnick DJ, Pearson SD, Henk HJ, Helstad CS.

Arch Gen Psychiatry. 2001 Feb;58(2):181-7.

PMID:
11177120
19.

Misdiagnosed patients with bipolar disorder: comorbidities, treatment patterns, and direct treatment costs.

Matza LS, Rajagopalan KS, Thompson CL, de Lissovoy G.

J Clin Psychiatry. 2005 Nov;66(11):1432-40.

PMID:
16420081
20.

Geriatric depression, antidepressant treatment, and healthcare utilization in a health maintenance organization.

Fischer LR, Wei F, Rolnick SJ, Jackson JM, Rush WA, Garrard JM, Nitz NM, Luepke LJ.

J Am Geriatr Soc. 2002 Feb;50(2):307-12.

PMID:
12028213

Supplemental Content

Support Center